How much revenue did GL Sciences generate this year?
GL Sciences has achieved a revenue of 37.15 B JPY this year.
GL Sciences Revenue 2024
GL Sciences Revenue
37.15 B JPY
Ticker
7705.T
ISIN
JP3385850007
In 2024, GL Sciences's sales reached 37.15 B JPY, a -3.96% difference from the 38.68 B JPY sales recorded in the previous year.
The GL Sciences Revenue history
| YEAR | REVENUE (undefined JPY) | GROSS MARGIN (%) |
|---|---|---|
| 2024 | 37.15 | 36,31 |
| 2023 | 38.68 | 34,67 |
| 2022 | 33.12 | 33,91 |
| 2021 | 29.22 | 33,47 |
| 2020 | 25.53 | 33,35 |
| 2019 | 24.8 | 35,30 |
| 2018 | 22.94 | 35,55 |
| 2017 | 20.58 | 35,03 |
| 2016 | 18.5 | 32,91 |
| 2015 | 18.14 | 33,32 |
| 2014 | 18.58 | 36,07 |
| 2013 | 16.74 | 35,35 |
| 2012 | 16.51 | 33,17 |
| 2011 | 16.22 | 33,07 |
| 2010 | 15.68 | 31,09 |
| 2009 | 16.32 | 28,95 |
| 2008 | 18.54 | 29,31 |
| 2007 | 18.98 | 30,39 |
| 2006 | 16.79 | 32,41 |
| 2005 | 16.66 | 32,22 |
GL Sciences Revenue, EBIT, Net Income JP3385850007 ·
3 years
5 years
10 years
25 Years
Max
Revenue
EBIT
Net Income
Details
Revenue, EBIT and Profit
ⓘUnderstanding Revenue, EBIT, and Income
Gain insights into GL Sciences, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by GL Sciences from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects GL Sciences’s net earnings, an ultimate measure of its financial health and profitability.
Yearly Analysis and Comparisons
Observe the yearly bars to understand the annual performance and growth of GL Sciences. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.
Utilizing Expectations for Investment
The expected values for the forthcoming years offer investors a glimpse into GL Sciences’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.
Investment Insights
Leveraging the comparison between Revenue and EBIT helps in assessing GL Sciences’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on GL Sciences’s growth potential.
GL Sciences Revenue, EBIT and net profit per share
| Date | GL Sciences Revenue | GL Sciences EBIT | GL Sciences Net Income |
|---|---|---|---|
| 2024 | 37.15 B undefined | 5.71 B undefined | 3.43 B undefined |
| 2023 | 38.68 B undefined | 6.03 B undefined | 3.5 B undefined |
| 2022 | 33.12 B undefined | 4.81 B undefined | 2.8 B undefined |
| 2021 | 29.22 B undefined | 3.85 B undefined | 2.26 B undefined |
| 2020 | 25.53 B undefined | 2.72 B undefined | 1.63 B undefined |
| 2019 | 24.8 B undefined | 2.99 B undefined | 2.01 B undefined |
| 2018 | 22.94 B undefined | 2.42 B undefined | 1.75 B undefined |
| 2017 | 20.58 B undefined | 1.8 B undefined | 1.32 B undefined |
| 2016 | 18.5 B undefined | 955.06 M undefined | 773.86 M undefined |
| 2015 | 18.14 B undefined | 887.52 M undefined | 632.73 M undefined |
| 2014 | 18.58 B undefined | 1.32 B undefined | 777 M undefined |
| 2013 | 16.74 B undefined | 1.05 B undefined | 526 M undefined |
| 2012 | 16.51 B undefined | 945 M undefined | 610 M undefined |
| 2011 | 16.22 B undefined | 738 M undefined | 372 M undefined |
| 2010 | 15.68 B undefined | 279 M undefined | 191 M undefined |
| 2009 | 16.32 B undefined | 49 M undefined | -152 M undefined |
| 2008 | 18.54 B undefined | 805 M undefined | 572 M undefined |
| 2007 | 18.98 B undefined | 1.2 B undefined | 592 M undefined |
| 2006 | 16.79 B undefined | 1.13 B undefined | 990 M undefined |
| 2005 | 16.66 B undefined | 1.07 B undefined | 466 M undefined |
| Revenue | EBIT | Net Income | |
|---|---|---|---|
| 2005 | 16.66 B JPY | 1.07 B JPY | 466 M JPY |
| 2006 | 16.79 B JPY | 1.13 B JPY | 990 M JPY |
| 2007 | 18.98 B JPY | 1.2 B JPY | 592 M JPY |
| 2008 | 18.54 B JPY | 805 M JPY | 572 M JPY |
| 2009 | 16.32 B JPY | 49 M JPY | -152 M JPY |
| 2010 | 15.68 B JPY | 279 M JPY | 191 M JPY |
| 2011 | 16.22 B JPY | 738 M JPY | 372 M JPY |
| 2012 | 16.51 B JPY | 945 M JPY | 610 M JPY |
| 2013 | 16.74 B JPY | 1.05 B JPY | 526 M JPY |
| 2014 | 18.58 B JPY | 1.32 B JPY | 777 M JPY |
| 2015 | 18.14 B JPY | 887.52 M JPY | 632.73 M JPY |
| 2016 | 18.5 B JPY | 955.06 M JPY | 773.86 M JPY |
| 2017 | 20.58 B JPY | 1.8 B JPY | 1.32 B JPY |
| 2018 | 22.94 B JPY | 2.42 B JPY | 1.75 B JPY |
| 2019 | 24.8 B JPY | 2.99 B JPY | 2.01 B JPY |
| 2020 | 25.53 B JPY | 2.72 B JPY | 1.63 B JPY |
| 2021 | 29.22 B JPY | 3.85 B JPY | 2.26 B JPY |
| 2022 | 33.12 B JPY | 4.81 B JPY | 2.8 B JPY |
| 2023 | 38.68 B JPY | 6.03 B JPY | 3.5 B JPY |
| 2024 | 37.15 B JPY | 5.71 B JPY | 3.43 B JPY |
GL Sciences stock margins JP3385850007 ·
The GL Sciences margin analysis displays the gross margin, EBIT margin, as well as the profit margin of GL Sciences. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for GL Sciences.
3 years
5 years
10 years
25 Years
Max
Gross margin
EBIT margin
Profit margin
Details
Margin
ⓘUnderstanding Gross Margin
The gross margin, expressed as a percentage, delineates the gross profit made from the GL Sciences's sales revenue. A higher gross margin percentage indicates that the GL Sciences retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.
EBIT Margin Analysis
EBIT margin represents the GL Sciences's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.
Revenue Margin Insights
The revenue margin demonstrates the GL Sciences's total revenue generated. When comparing the revenue margin year over year, investors can gauge the GL Sciences's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.
Interpreting Expectations
The expected values for gross, EBIT, and revenue margins provide future financial outlook of the GL Sciences. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.
Comparative Analysis
Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the GL Sciences's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.
GL Sciences Margin History
| GL Sciences Gross margin | GL Sciences Profit margin | GL Sciences EBIT margin | GL Sciences Profit margin |
|---|---|---|---|
| 2024 | 36.31 % | 15.38 % | 9.24 % |
| 2023 | 34.67 % | 15.6 % | 9.05 % |
| 2022 | 33.91 % | 14.51 % | 8.44 % |
| 2021 | 33.47 % | 13.16 % | 7.73 % |
| 2020 | 33.35 % | 10.64 % | 6.4 % |
| 2019 | 35.3 % | 12.05 % | 8.09 % |
| 2018 | 35.55 % | 10.54 % | 7.62 % |
| 2017 | 35.03 % | 8.75 % | 6.41 % |
| 2016 | 32.91 % | 5.16 % | 4.18 % |
| 2015 | 33.32 % | 4.89 % | 3.49 % |
| 2014 | 36.07 % | 7.09 % | 4.18 % |
| 2013 | 35.35 % | 6.27 % | 3.14 % |
| 2012 | 33.17 % | 5.72 % | 3.69 % |
| 2011 | 33.07 % | 4.55 % | 2.29 % |
| 2010 | 31.09 % | 1.78 % | 1.22 % |
| 2009 | 28.95 % | 0.3 % | -0.93 % |
| 2008 | 29.31 % | 4.34 % | 3.09 % |
| 2007 | 30.39 % | 6.33 % | 3.12 % |
| 2006 | 32.41 % | 6.71 % | 5.9 % |
| 2005 | 32.22 % | 6.4 % | 2.8 % |
| Gross margin | EBIT margin | Profit margin | |
|---|---|---|---|
| 2005 | 32.22 % | 6.4 % | 2.8 % |
| 2006 | 32.41 % | 6.71 % | 5.9 % |
| 2007 | 30.39 % | 6.33 % | 3.12 % |
| 2008 | 29.31 % | 4.34 % | 3.09 % |
| 2009 | 28.95 % | 0.3 % | -0.93 % |
| 2010 | 31.09 % | 1.78 % | 1.22 % |
| 2011 | 33.07 % | 4.55 % | 2.29 % |
| 2012 | 33.17 % | 5.72 % | 3.69 % |
| 2013 | 35.35 % | 6.27 % | 3.14 % |
| 2014 | 36.07 % | 7.09 % | 4.18 % |
| 2015 | 33.32 % | 4.89 % | 3.49 % |
| 2016 | 32.91 % | 5.16 % | 4.18 % |
| 2017 | 35.03 % | 8.75 % | 6.41 % |
| 2018 | 35.55 % | 10.54 % | 7.62 % |
| 2019 | 35.3 % | 12.05 % | 8.09 % |
| 2020 | 33.35 % | 10.64 % | 6.4 % |
| 2021 | 33.47 % | 13.16 % | 7.73 % |
| 2022 | 33.91 % | 14.51 % | 8.44 % |
| 2023 | 34.67 % | 15.6 % | 9.05 % |
| 2024 | 36.31 % | 15.38 % | 9.24 % |
GL Sciences Aktienanalyse
What does GL Sciences do?
GL Sciences ist eines der beliebtesten Unternehmen auf Eulerpool.com.Revenue Details
Understanding GL Sciences's Sales Figures
The sales figures of GL Sciences originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.
Year-to-Year Comparison
Analyzing GL Sciences’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.
Impact on Investments
Investors often scrutinize GL Sciences's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.
Interpreting Sales Fluctuations
Increases in GL Sciences’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.
Frequently Asked Questions about GL Sciences stock
How much was the turnover of the company GL Sciences compared to the previous year?
The revenue of GL Sciences has increased by -3.96% decreased compared to the previous year.
What does revenue mean for investors?
The revenue of a company is an important indicator of its financial performance and attractiveness for investors.
Which factors influence the revenue of GL Sciences?
The revenue of GL Sciences is influenced by various factors, including the demand for its products and services, market conditions, and prices.
How is the revenue of GL Sciences measured?
Revenue is typically measured in units referring to the sale of goods and services provided by the company.
How does an increase in sales affect investments?
An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.
What are the possible risks associated with a declining revenue?
A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.
Why is the sales revenue of GL Sciences so important for investors?
The revenue of GL Sciences is an important indicator of financial performance and attractiveness for investors.
What strategic measures can a company take to increase revenue?
A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.
How much dividend does GL Sciences pay?
Over the past 12 months, GL Sciences paid a dividend of 70 JPY . This corresponds to a dividend yield of about 2.48 %. For the coming 12 months, GL Sciences is expected to pay a dividend of 70 JPY.
What is the dividend yield of GL Sciences?
The current dividend yield of GL Sciences is 2.48 %.
When does GL Sciences pay dividends?
GL Sciences pays a quarterly dividend. This is distributed in the months of April, April, April, April.
How secure is the dividend of GL Sciences?
GL Sciences paid dividends every year for the past 20 years.
What is the dividend of GL Sciences?
For the upcoming 12 months, dividends amounting to 70 JPY are expected. This corresponds to a dividend yield of 2.48 %.
In which sector is GL Sciences located?
GL Sciences is assigned to the 'Information technology' sector.
Wann musste ich die Aktien von GL Sciences kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of GL Sciences from 6/1/2024 amounting to 70 JPY, you needed to have the stock in your portfolio before the ex-date on 3/28/2024.
When did GL Sciences pay the last dividend?
The last dividend was paid out on 6/1/2024.
What was the dividend of GL Sciences in the year 2023?
In the year 2023, GL Sciences distributed 60 JPY as dividends.
In which currency does GL Sciences pay out the dividend?
The dividends of GL Sciences are distributed in JPY.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von GL Sciences
Our stock analysis for GL Sciences Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of GL Sciences Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.